Private Trust Company’s Novavax NVAX Stock Holding History

Private Trust Company’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-120	Closed	-$1.52K	–	2384
2024 Q3	$1.52K	Hold	120	–	–	﹤0.01%	2177
2024 Q2	$1.52K	Sell	120 -80	-40%	-$805	﹤0.01%	2174
2024 Q1	$956	Hold	200	–	–	﹤0.01%	2162
2023 Q4	$960	Hold	200	–	–	﹤0.01%	2206
2023 Q3	$1.45K	Hold	200	–	–	﹤0.01%	2167
2023 Q2	$1.49K	Hold	200	–	–	﹤0.01%	2147
2023 Q1	$1.39K	Buy	+200	New	+$1.84K	﹤0.01%	2125

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Private Trust Company's NVAX Position: Q4 2024 in Review

Private Trust Company sold out of Novavax (NVAX) in Q4 2024, closing a stake of 120 shares — an estimated $1.52K sold.

Private Trust Company first reported a position in NVAX in Q1 2023 and held it in 7 quarters. The position peaked at $1.52K in Q2 2024. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

Private Trust Company reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
Private Trust Company sold 120 Novavax shares in Q4 2024, an estimated $1.52K.
Private Trust Company first reported a position in Novavax in Q1 2023 and held it in 7 quarters.
Private Trust Company's Novavax position peaked at $1.52K in Q2 2024.
234 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Private Trust Company's 13F filing for Q4 2024, filed 5 Feb 2025.